Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506410 | PMC |
| http://dx.doi.org/10.5114/aic.2024.143686 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
MicroNET-covered stent 'sandwich' technique to seal carotid artery perforation in a highly-calcific lesion.
Postepy Kardiol Interwencyjnej
December 2024
Department of Cardiac and Vascular Diseases, Jagiellonian University, Krakow, Poland.
Commentary: A multi-center study of the MicroNET-covered stent in consecutive patients with acute carotid-related stroke: SAFEGUARD-STROKE.
Postepy Kardiol Interwencyjnej
September 2024
Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
MicroNET-covered stent (CGuard) routine use in acute carotid-related stroke - SAFEGUARD-STROKE Study: response to the Buffalo Group commentary.
Postepy Kardiol Interwencyjnej
September 2024
St. John Paul II Hospital in Krakow, Stroke Thrombectomy-Capable Cardiovascular Centre, Krakow, Poland.
Endovascular resolution of MicroNET-covered stent inadvertent implantation from the external to common carotid artery.
Postepy Kardiol Interwencyjnej
September 2024
Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Krakow, Poland.
A multi-center study of the MicroNET-covered stent in consecutive patients with acute carotid-related stroke: SAFEGUARD-STROKE.
Postepy Kardiol Interwencyjnej
June 2024
St. John Paul II Hospital in Krakow Stroke Thrombectomy-Capable Cardiovascular Centre, Krakow, Poland.
Introduction: Acute carotid-related stroke (CRS), with its large thrombo-embolic load and large volume of affected brain tissue, poses significant management challenges. First generation (single-layer) carotid stents fail to insulate the athero-thrombotic material; thus they are often non-optimized (increasing thrombosis risk), yet their use is associated with a significant (20-30%) risk of new cerebral embolism.
Aim: To evaluate, in a multi-center multi-specialty investigator-initiated study, outcomes of the MicroNET-covered (cell area ≈ 0.